Junshi receives China’s NMPA acceptance for toripalimab injectionPharmaceutical Technology·Mar 10 at 05:43 AM44018159506+1.00%
OBiO Tech: Net loss of 105 million yuan in the first half of 2025, a year-on-year narrowingZhitong·Aug 18, 2025 at 03:59 AM688238+0.36%
OBiO Tech plans to promote a restricted stock incentive plan of 3.7454 million sharesZhitong·Jun 27, 2025 at 07:45 AM688238+0.36%
Zhengzhou Airport Economic Zone in Henan and OBiO Tech have strategic cooperation plans to build a "cell factory" and pilot the development of the cell gene therapy industryZhitong·Jun 15, 2025 at 09:46 PM688238+0.36%
OBiO Tech shareholder Huairuishengyin and its concerted parties plan to reduce their holdings by no more than 1%Zhitong·May 8, 2025 at 06:31 PM688238+0.36%
CRO concept stocks fluctuate and strengthen, PR rises over 10%36Kr·Apr 28, 2025 at 09:17 PM603259+2.83%02359+1.28%
OBiO Tech released its first-quarter performance, with a net loss attributable to the parent company of 59.4773 million yuan, an increase in lossesZhitong·Apr 23, 2025 at 04:40 AM688238+0.36%
OBiO Tech released its 2024 annual performance, with a net loss attributable to the parent company of 322 million yuan, an expanded lossZhitong·Apr 17, 2025 at 08:58 AM688238+0.36%
OBiO Tech: Shareholder's reduction plan period has expired without reducing company sharesZhitong·Mar 19, 2025 at 09:44 AM688238+0.36%
Core technical staff of OBiO Tech, Wei Houliang, has left the companyZhitong·Mar 17, 2025 at 05:02 AM688238+0.36%
OBiO Tech's approximately 174 million restricted shares will be listed and circulated on March 24Zhitong·Mar 13, 2025 at 04:30 AM688238+0.36%
OBiO Tech faced a reduction of 900,000 shares by shareholder Shanghai Tan Ying and its concerted partiesZhitong·Mar 6, 2025 at 05:25 AM688238+0.36%
OBiO Tech's net loss for the fiscal year 2024 is 325 million yuan, with losses wideningZhitong·Feb 26, 2025 at 03:36 AM688238+0.36%
OBiO Tech: Plans to repurchase shares for 50 million to 100 million yuanZhitong·Feb 20, 2025 at 04:28 AM688238+0.36%
